Fingolimod impurities include process-related substances, degradation products, and structurally related analogs that may arise during synthesis, formulation, or storage. As a sphingosine-1-phosphate receptor modulator used in the treatment of multiple sclerosis, impurity profiling is essential to ensure product safety, therapeutic efficacy, and regulatory compliance. All impurity materials are structurally characterized and qualified under ICH guidelines for toxicological evaluation and analytical validation.
We offer pharmacopeial and non-pharmacopeial Fingolimod impurities that conform to European Pharmacopoeia (EP) specifications. These standards support method development, impurity profiling, and stability studies. EP traceable materials are available upon request and are supplied with validated analytical data including HPLC purity, NMR, and MS characterization.
Our catalog includes structurally related compounds and synthetic intermediates associated with Fingolimod. These materials are used in forced degradation studies, impurity identification, and genotoxicity assessments. Fingolimod is derived from the natural product myriocin, and its analogs have been explored for antibacterial and anticancer applications.
Fingolimod impurity reference standards are supplied with validated analytical data including NMR, MS, and HPLC purity. These materials are used in pharmaceutical R&D, method validation, and GMP-compliant quality control. EP/USP traceable entries are available upon request. All products are re-tested at regular intervals to ensure consistency and reliability.
Address
Plot No. CP-135, Pimpri-Chinhwad MIDC, Pune-411019, Maharashtra, India.
© 2014-2024 SynThink Research Chemicals. All Rights Reserved.
Register to add the product to RFQ list
Already have an account? Log in here
Don’t have an account? Register here
